In addition, osteopontin released by cancer-associated mesothelial cells has been shown to induce chemoresistance via activation of CD44, PI3K-AKT signaling, and ABC drug transporter in ovarian cancer cells in vitro (40). Here, CD44 is linked to ovarian cancer.